Non-invasive detection of hippocampal sclerosis: Correlation between metabolite alterations detected by 1H-MRS and neuropathology

NMR in Biomedicine

Volumn 21, Issue 6, 2008, Pages 545-552

  Hammen, Thilo ^a   Hildebrandt, Michelle ^a   Stadlbauer, Andreas ^a   Doelken, Marc ^a   Engelhorn, Tobias ^a   Kerling, Frank ^a   Kasper, Burkhard ^a   Romstoeck, Johann ^a   Ganslandt, Oliver ^a   Nimsky, Christopher ^a   Blumcke, Ingmar ^a   Doerfler, Arndt ^a   Stefan, Hermann ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

1H MRS; Astrogliosis; Glial fibrillary acid protein (GFAP); Hippocampal sclerosis; Neuronal cell count; Temporal lobe epilepsy (TLE)

Indexed keywords

1H-MRS; ASTROGLIOSIS; GLIAL FIBRILLARY ACID PROTEIN (GFAP); HIPPOCAMPAL SCLEROSIS; NEURONAL CELL COUNT; NON-INVASIVE DETECTION; TEMPORAL LOBE EPILEPSY (TLE);

ANTICONVULSIVE AGENT; GLIAL FIBRILLARY ACIDIC PROTEIN; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOSIS; BRAIN NERVE CELL; BRAIN SURGERY; CELL DENSITY; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; GLIOSIS; HIPPOCAMPAL SCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE DISPLAY; MALE; METABOLITE; NEUROPATHOLOGY; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; RISK FACTOR; TEMPORAL LOBE EPILEPSY;

ADOLESCENT; ADULT; ASPARTIC ACID; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; EPILEPSY, TEMPORAL LOBE; FEMALE; HIPPOCAMPUS; HUMANS; INFANT; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS; REPRODUCIBILITY OF RESULTS; SCLEROSIS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; TISSUE DISTRIBUTION;

EID: 48349146871     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1222     Document Type: Article

References (39)

1. Cendes F, Andermann F, Preul MC, Arnold DL. Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images. Ann Neurol 1994; 35(2): 211-216.
2. Cendes F, Caramanos Z, Andermann F, Dubeau F, Arnold DL. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Ann Neurol 1997; 42(5): 737-746.
3. Simister RJ, Woermann FG, McLean MA, Bartlett PA, Barker GJ, Duncan JS. A short-echo-time proton magnetic resonance spectroscopic imaging study of temporal lobe epilepsy. Epilepsia 2002; 43(9): 1021-1031.
4. Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 1994; 44(8): 1411-1417.
5. Kuzniecky R, Palmer C, Hugg J, Martin R, Sawrie S, Morawetz R, Faught E, Knowlton R. Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: neuronal dysfunction or cell loss? Arch Neurol 2001; 58(12): 2048-2053.
6. Chang KH, Kim HD, Park SW, Song IC, Yu IK, Han MH, Lee SK, Chung CK, Park YH. Usefulness of single voxel proton MR spectroscopy in the evaluation of hippocampal sclerosis. Korean J Radiol 2000; 1(1): 25-32.
7. Stadlbauer A, Gruber S, Nimsky C, Fahlbusch R, Hammen T, Buslei R, Tomandl B, Moser E, Ganslandt O. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 2006; 238(3): 958-969.
8. Fountas KN, Kapsalaki EZ, Vogel RL, Fezoulidis I, Robinson JS, Gotsis ED. Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Stereotact Funct Neurosurg 2004; 82(2-3): 90-97.
9. 1H MRS analysis of human brain tumors. Anticancer Res 1996; 16(3B): 1559-1563.
10. 1H magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumours. Acta Neurochir Suppl 1997; 68: 127-132.
11. Likavcanova K, Dobrota D, Liptaj T, Pronayova N, Mlynarik V, Belan V, Galanda M, Beres A, De Riggo J. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy. Gen Physiol Biophys 2005; 24(3): 327-335.
12. Stefan H. Use of newer diagnostic techniques in patient management. Epilepsy Res Suppl 1996; 11: 199-209.
13. Duvernoy HM. The Human Hippocampus. Springer Verlag: Berlin, Heidelberg, 2005.
14. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30(6): 672-679.
15. 1H spectra with LCModel. NMR Biomed 2001; 14(4): 260-264.
16. Helms G. Analysis of 1.5 Tesla proton MR spectra of human brain using LCModel and an imported basis set. Magn Reson Imaging 1999; 17(8): 1211-1218.
17. Helms G. A precise and user-independent quantification technique for regional comparison of single volume proton MR spectroscopy of the human brain. NMR Biomed 2000; 13(7): 398-406.
18. 1H-MR spectroscopy of hippocampal structures in healthy adults at 1.5 Tesla: how reproducible are the results? NMR Biomed 2005; 18(3): 195-201.
19. Blümcke I, Pauli E, Clusmann H, Schramm J, Becker A, Elger CE, Merschhemke M, Meencke HJ, Lehmann T, Deimling A, Schweiwe C, Zentner J, Volk B, Romstöck J, Stefan H, Hildebrandt M. A new clinico-pathological classification of mesial temporal sclerosis. Acta Neuropathol (Berl) 2007; 113(3): 235-244.
20. Pauli E, Hildebrandt M, Romstock J, Stefan H, Blumcke I. Deficient memory acquisition in temporal lobe epilepsy is predicted by hippocampal granule cell loss. Neurology 2006; 67(8): 1383-1389.
21. Wieser HG. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 2004; 45(6): 695-714.
22. 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann Neurol 1999; 45(3): 369-376.
23. 1H magnetic resonance spectroscopy at 3 T in cryptogenic and mesial temporal lobe epilepsy. NMR Biomed 2006; 19(5): 544-553.
24. 1H MRS in vivo. Neuroreport 1994; 5(14): 1733-1736.
25. Ross BD, Danielsen ER, Bluml S. Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Dig Dis 1996; 14 (Suppl 1): 30-39.
26. Bitsch A, Bruhn H, Vougioukas V, Stringaris A, Lassmann H, Frahm J, Bruck W. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999; 20(9): 1619-1627.
27. Schuhmann MU, Stiller D, Skardelly M, Bernarding J, Klinge PM, Samii A, Samii M, Brinker T. Metabolic changes in the vicinity of brain contusions: a proton magnetic resonance spectroscopy and histology study. J Neurotrauma 2003; 20(8): 725-743.
28. Mueller SG, Laxer KD, Suhy J, Lopez RC, Flenniken DL, Weiner MW. Spectroscopic metabolic abnormalities in mTLE with and without MRI evidence for mesial temporal sclerosis using hippocampal short-TE MRSI. Epilepsia 2003; 44(7): 977-980.
29. Wellard RM, Briellmann RS, Prichard JW, Syngeniotis A, Jackson GD. Myoinositol abnormalities in temporal lobe epilepsy. Epilepsia 2003; 44(6): 815-821.
30. Margerison JH, Corsellis JA. Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 1966; 89(3): 499-530.
31. 1H magnetic resonance spectroscopic imaging. Neurology 1993; 43(3 Pt 1): 509-515.
32. 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo. Magn Reson Imaging 1998; 16(8): 969-979.
33. Block W, Traber F, Flacke S, Jessen F, Pohl C, Schild H. In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration. Amino Acids 2002; 23(1-3): 317-323.
34. Dautry C, Vaufrey F, Brouillet E, Bizat N, Henry PG, Conde F, Bloch G, Hantraye P. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J Cereb Blood Flow Metab 2000; 20(5): 789-799.
35. Hugg JW, Laxer KD, Matson GB, Maudsley AA, Weiner MW. Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1993; 34(6): 788-794.
36. Stefan H, Feichtinger M, Pauli E, Schafer I, Eberhardt KW, Kasper BS, Hopp P, Buchfelder M, Huk J, Paulus W. Magnetic resonance spectroscopy and histopathological findings in temporal lobe epilepsy. Epilepsia 2001; 42(1): 41-46.
37. Cohen-Gadol AA, Pan JW, Kim JH, Spencer DD, Hetherington HH. Mesial temporal lobe epilepsy: a proton magnetic resonance spectroscopy study and a histopathological analysis. J Neurosurg 2004; 101(4): 613-620.
38. Petroff OA, Errante LD, Kim JH, Spencer DD. N-acetyl-aspartate, total creatine, and myo-inositol in the epileptogenic human hippocampus. Neurology 2003; 60(10): 1646-1651.
39. 1H-MRS and un-biased stereology: can non-invasive measures of N-acetyl-asparate following global ischemia be used as a reliable measure of neuronal damage? Brain Res 2001; 892(1): 166-175.